SkyscraperCity Forum banner
1 - 5 of 5 Posts

· The City
7,187 Posts
Discussion Starter · #1 ·
Okay, don't get too excited. Only about 75 new jobs will be created, and the the rest of the jobs were already here. But Deerfield is now the US Headquarters of a major worldwide pharmaceutical from Japan, previously HQ in New Jersey. Probably not a big deal, other than bragging rights:

Japanese drugmakers strengthen area ties

Published March 31, 2005

Japanese drugmakers are keeping their roots firmly planted in the Chicago area.

Effective Friday, Astellas Pharma U.S. Inc. will list the address of its U.S. headquarters as Deerfield, the longtime home of Fujisawa Healthcare Inc.

The Astellas name replaces Fujisawa as a result of Fujisawa's recently completed merger with Yamanouchi Pharmaceutical Co. of Tokyo. Yamanouchi's U.S. headquarters had been in New Jersey but will now be in Deerfield.

Under the Astellas name, the combined Fujisawa-Yamanouchi operation has annual worldwide sales of about $8 billion, putting the company among the top 20 drugmakers in the world.

"As Astellas, we will build on nearly two centuries of collective experience to create a unique place in the U.S. pharmaceutical landscape, where true innovation is valued and rewarded," said Makoto Nishimura, chairman and chief executive of Astellas Pharma U.S. Inc.

In Japan, Astellas is second only to Takeda Pharmaceutical Co., which has more than $10 billion in annual worldwide sales. Like Astellas, Takeda has its U.S. base here, with offices in suburban Lincolnshire under the name Takeda Pharmaceuticals North America Inc. Takeda also owns half of Lake Forest-based TAP Pharmaceutical Products Inc., with partner Abbott Laboratories.

The United States has long been an important market for Japanese drugmakers, especially since there are no price controls in the U.S. as there are in their country, so selling drugs is more profitable here.

Astellas' flagship product is Prograf, one of the nation's best-selling brand-name medicines, used to prevent liver and kidney transplant patients from rejecting their new organs. Prograf generated more than $500 million in U.S. sales last year for the former Fujisawa.

"We believe that our long-term strategy for growing established franchise businesses will distinguish us as a company focused on developing breakthrough treatments rather than only blockbuster products," Nishimura said.

In line with its decision to keep the larger company's offices here, Astellas is creating 75 new positions and retaining the 350 Fujisawa jobs that had already been in Deerfield.

The firm gave some credit to the administration of Gov. Rod Blagojevich, which last year agreed to give a $500,000 grant and tax credits worth nearly $8 million to help keep the U.S. headquarters in Illinois.

Bridge extends credit line: Bridge Healthcare Finance said it has extended a $7.5 million line of credit to the Neurologic & Orthopedic Institute of Chicago, a specialty surgical hospital located on Chicago's North Side.

Chicago-based Bridge assists health-care companies with a variety of financial services. The institute plans to use the line of credit for "general working capital," a Bridge spokeswoman said.

The institute opened in 2003 on the campus of the former Ravenswood Hospital as one of the area's first investor-owned specialty hospitals, dedicated primarily to brain, spine and orthopedic surgery.

· born again cyclist
3,908 Posts
it's not a very big deal in the grand scheme of things, but the way in which chicagoland's corporate HQ presence had been battered by mergers over the past 10 years or so, it's ALWAYS nice to hear when chicago comes out as the winner of a merger, even if the company will be headquartered out in bumblefuck deerfield.

· Banned
117 Posts
sharptent said:
it's not a very big deal in the grand scheme of things, but the way in which chicagoland's corporate HQ presence had been battered by mergers over the past 10 years or so, it's ALWAYS nice to hear when chicago comes out as the winner of a merger, even if the company will be headquartered out in bumblefuck deerfield.
So, you consider the suburbs Chicago?

· Registered
1,038 Posts
Chicago snags online retail HQ from Silicon Valley
GlobalNetXchange bring major retailers, suppliers together

By Sandra Jones
GlobalNetXchange LLC, an online marketplace for retailers including Sears Holdings Corp. and Walgreen Co., is moving its corporate headquarters to Chicago from San Francisco. The company, formed in 2000 by eight giant retailers including France’s Carrefour SA and Sears, intends to employ a headquarters staff of 100. It is leasing 27,000 square feet at 200 West Monroe St.

GNX began to move its operations to Chicago in February and plans to be fully staffed by September. About 10 workers from San Francisco have relocated. The remaining 90 workers—from accountants to software engineers—are being hired locally. The office currently has 40 employees.
Other cities in contention for the headquarters included Washington D.C., New York and Cincinnati.

The reason we chose Chicago is its geographical location,” says Joe Laughlin, CEO of GNX. “Chicago is in the central part of the U.S. and closer to Europe, so we’re closer to our customers. It also gives us access to a good labor pool.”

Closely held GNX had 2004 sales of about $25 million in 2004, according to Mr. Laughlin. It is scheduled to merge with rival Alexandria, Va.-based WorldWide Retail Exchange LLC at the end of June.

The combined company, which will be renamed, will keep the Chicago headquarters. It will also have offices in, Alexandria, Va., Tokyo and London, and Melbourne, Australia.

“It’s always good when we can bring a tech company out of Silicon Valley,” says Paul O’Connor, executive director of World Business Chicago. “It’s a good thing to have one of the biggest retail players in the world in Chicago.

The combined online exchange is aimed at making it easier and more cost efficient for retailers to hook up with suppliers and better compete against the muscle of supply-chain expert Wal-Mart Stores Inc.
1 - 5 of 5 Posts
This is an older thread, you may not receive a response, and could be reviving an old thread. Please consider creating a new thread.